Abstract
Retinoids and vitamin D are known to exert important anti-tumour effects in a variety of cell types.
In this study the effects of 9-cis-retinoic acid (9cRA) the vitamin D analogues EB1089 and CB1093 on three pancreatic adenocarcinoma cell lines were investigated.
All compounds caused inhibition of in vitro growth but the vitamin D analogues were generally the more potent growth inhibitors. They were also more effective on their own than in combination with 9cRA.
Growth arrest correlated with an increased proportion of cells in the G0/G1 phase.
Apoptosis was induced in the three cell lines by 9cRA, whereas neither EB1089 nor CB1093 had this effect.
Furthermore, addition of EB1089 or CB1093 together with 9cRA resulted in significantly reduced apoptosis.
Our results show that retinoic acids as well as vitamin D analogues have inhibitory effects on pancreatic tumour cells but different and antagonistic mechanisms seem to be employed.
See also:
- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives);
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- Vitamin D (analogues and/or derivatives) and cancer;
- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;
- Complete objective response to biological therapy of plurifocal breast carcinoma;